Fed. Circ. Grills USPTO On Hirshfeld's Power In Arthrex Fight
A Federal Circuit panel weighed the latest installment in the ongoing Arthrex saga Wednesday, pressing the government on its argument that a longstanding U.S. Patent and Trademark Office directive authorizes Drew Hirshfeld, the interim leader of the agency, to implement the U.S. Supreme Court's Arthrex remedy.